Cargando…
Ketogenic therapies for glioblastoma: Understanding the limitations in transitioning from mice to patients
Glioblastoma Multiforme is an aggressive brain cancer affecting children and adults frequently resulting in a short life expectancy. Current cancer therapies include surgery and radiation followed by chemotherapy, which due to their ineffectiveness, requires repeated exposure to the same therapies....
Autor principal: | Clontz, Angela D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10029602/ https://www.ncbi.nlm.nih.gov/pubmed/36960210 http://dx.doi.org/10.3389/fnut.2023.1110291 |
Ejemplares similares
-
Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up
por: Elsakka, Ahmed M. A., et al.
Publicado: (2018) -
Editorial: The use of ketogenic diet therapy in the era of individualized therapy
por: Ünalp, Aycan, et al.
Publicado: (2023) -
Association of hypercalciuria with vitamin D supplementation in patients undergoing ketogenic dietary therapy
por: Lee, Myeongseob, et al.
Publicado: (2022) -
Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of IDH1-Mutant Glioblastoma: An 80-Month Follow-Up Case Report
por: Seyfried, Thomas N., et al.
Publicado: (2021) -
A Root in Synapsis and the Other One in the Gut Microbiome-Brain Axis: Are the Two Poles of Ketogenic Diet Enough to Challenge Glioblastoma?
por: Montella, Liliana, et al.
Publicado: (2021)